PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNabriva Therapeutics
Nabriva Therapeutics(NBRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XenletaLefamulin2020-07-272028-2031
Community-acquired infections
,
Bacterial pneumonia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lefamulin
healthy volunteers/patients
,
fibrosis
,
cystic fibrosis
,
infections
,
bacterial infections
,
mycoplasma infections
,
pleuropneumonia
,
mycoplasma genitalium
,
pneumonia
,
community-acquired pneumonia
Fosfomycin
infections
,
urinary tract infections
,
communicable diseases
,
pyelonephritis
Bevifimod
clostridium infections
Lactams
neoplasms
,
recurrence
,
non-hodgkin lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
macular degeneration
,
wet macular degeneration
,
choroidal effusions
,
infections
,
communicable diseases
,
bacterial infections
,
methicillin-resistant staphylococcus aureus
,
staphylococcal skin infections
,
infectious skin diseases
,
bacterial skin diseases
,
cellulitis
Trinessa
healthy volunteers/patients
,
diabetes mellitus
,
pharmacokinetics
,
major depressive disorder
,
neoplasms
,
long qt syndrome
,
alzheimer disease
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
respiration disorders
,
emphysema
,
bronchiolitis
,
rheumatoid arthritis
,
non-alcoholic fatty liver disease
,
alcoholic fatty liver
,
sepsis
,
septic shock
Fluoroquinolone
healthy volunteers/patients
Isoxaflutole
therapeutic equivalency
,
healthy volunteers/patients
,
heart failure
,
cardiovascular diseases
,
heart diseases
,
cardiac arrhythmias
,
laparoscopy
,
growth
,
obesity
,
diet therapy
,
acute lung injury
,
lung injury
,
type 2 diabetes mellitus
,
body weight changes
,
atrial fibrillation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use